Estrella Immunopharma, Inc. (ESLA) — 分析师展望 / 分析师共识目标价为. 基于 1 位分析师评级, 共识为 看涨 — 1 买入.
分析师预估 每股收益(EPS)为 $-0.46 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.25 vs 预期 $-0.46 (超预期 +45.7%). 2025: 实际 $-0.35 vs 预期 $-0.72 (超预期 +51.4%). 分析师准确度: 5%.
ESLA 分析师评级
Buy
基于过去3个月内 1 位分析师对 Estrella Immunopharma, Inc. 的评级
EPS 预测 — ESLA
5%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.25
vs Est –$0.46
▲ 84.0% off
2025
Actual –$0.35
vs Est –$0.72
▲ 105.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — ESLA
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
